|
| | Issue Date | Title | Author(s) |
| 1 | 6-Nov-2025 | Anti-aflatoxigenic effect of Lactobacillus rhamnosus and its synbiotic combination of chitosan/ZnO in milk | Riad, Omnia Karem M; Selim, Heba Mohammed Refat M; Tohamy, Sally T K; Aboshanab, Khaled |
| 2 | Nov-2025 | Genomic analysis and preclinical evaluation of two hydrogel-formulated novel virulent phages isolated against a carbapenem-resistant Acinetobacter baumannii | Elshamy, Ann A; Kamal, Sandra K; Mahmoud, Mariam T; Elhasany, Aya M; Shady, Aya A; Mohamed, Sherok A; Abd-Elmaaboud, Hasna A; El-Awady, Nour E; Mohamed, Rana A; El-Mirghany, Sara A; El-Hady, Sarraa W; Abd-ElRahman, Mohamed M; Saad, Bishoy T; Alshahrani, Mohammad Y; Aboshanab, Khaled ; Mabrouk, Samar S |
| 3 | 27-Oct-2025 | Antibacterial, antibiofilm and cytotoxic properties of Aloe vera-synthesized silver titanium nanoparticles | Abouelwafa, Mariam Z; Saleh, Sarra E; Hussien, Mai S A; Yahia, Ibrahim S; Aboshanab, Khaled |
| 4 | 17-Sep-2025 | Antibacterial, antibiofilm and cytotoxic activity of synthesized metal-incorporated mesoporous silica nanoparticles | Shehata, Suzan; Elkholy, Yomna N; Hussien, Mai S A; Yahia, Ibrahim S; Aboshanab, Khaled |
| 5 | 16-Sep-2025 | Pristinamycin-antibiotic combinations against methicillin-resistant Staphylococcus aureus recovered from skin infections | Suliman, Muath; Bishr, Amr S; Tohamy, Sally T K; Mabrouk, Samar S; Ismail, Nasser S M; Samy, Abdallah M; Aboshanab, Khaled |
| 6 | Sep-2025 | Evaluation of the taxonomic classification tools and visualizers for metagenomic analysis using the Oxford nanopore sequence database | Bebawy, Abraam S; Saad, Bishoy T; Saad, Mina T; Mosaad, Gamal S; Gomaa, Fatma Alzahraa M; Alshahrani, Mohammad Y; Aboshanab, Khaled |
| 7 | Sep-2025 | Solid-state fermentation of pristinamycin by Streptomyces pristinaespiralis NRRL ISP-5338 using D-optimal design | Suliman, Muath; Bishr, Amr S; Tohamy, Sally T K; Alshahrani, Mohammad Y; Aboshanab, Khaled |
| 8 | 11-Aug-2025 | Recent insights on challenges encountered with phage therapy against gastrointestinal-associated infections | Youssef, Reem A; Shebl, Rania I; Aboshanab, Khaled ; Sakr, Masarra M |
| 9 | 2-Aug-2025 | Genomic characterization and pre-clinical evaluation of a new polyvalent lytic Loughborough phage | Sherif, Mahmoud M; Abdelaziz, Neveen A; Saleh, Sarra E; Aboshanab, Khaled |
| 10 | 18-Jun-2025 | Anticancer, antimicrobial and molecular docking analysis of newly synthesized iodoquinazoline derivatives | Aboshanab K. M. ; Bishr, Amr S; Jusoh, Siti Azma; Alshahrani, Mohammad Y; Rahman, Khondaker Miraz; Alafeefy, Ahmed M |
| 11 | 20-May-2025 | D-optimal design model and biosynthetic pathway for gentamicin production by Micromonospora purpureochromogenes NRRL B-16094 | Suliman, Muath; Bishr, Amr S; Tohamy, Sally T K; Alshahrani, Mohammad Y; Aboshanab, Khaled |
| 12 | 17-May-2025 | In vitro, genomic characterization and pre-clinical evaluation of a new thermostable lytic Obolenskvirus phage formulated as a hydrogel against carbapenem-resistant Acinetobacter baumannii | Sherif, Mahmoud M; Abdelaziz, Neveen A; Alshahrani, Mohammad Y; Saleh, Sarra E; Aboshanab, Khaled |
| 13 | 28-Apr-2025 | Deciphering hygromycin B biosynthetic pathway and D-optimal design for production optimization | Suliman, Muath; Bishr, Amr S; Aboshanab, Khaled |
| 14 | 26-Apr-2025 | A novel thermostable lytic phage vB_EF_Enf3_CCASU-2024-3 against clinical Enterococcus faecium and Enterococcus faecalis | Amr, Rana M; Bishr, Amr S; Saad, Bishoy T; Alshahrani, Mohammad Y; Aboshanab, Khaled ; Hassouna, Nadia A |
| 15 | 1-Apr-2025 | In vitro and preclinical evaluation of the antifungal activity of 6-methoxy-1 H-indole-2-carboxylic acid produced by Bacillus toyonensis strain OQ071612 formulated as nanosponge hydrogel | El-Sayed, Sayed E; Abdelaziz, Neveen A; El-Housseiny, Ghadir S; Aboshanab, Khaled |
| 16 | 1-Apr-2025 | Role of CRISPR-Cas system as a new approach in fighting the antimicrobial resistance of bacterial and viral pathogens | Selim, Heba Mohammed Refat M.; Gomaa, Fatma Alzahraa M.; Alshahrani, Mohammad Y.; Aboshanab K.M.A |
| 17 | 12-Mar-2025 | Recent insights on phage therapy against multidrug-resistant Acinetobacter baumannii | Elshamy, Ann A; Kamal, Sandra K; Mahmoud, Mariam T; Elhasany, Aya M; Shady, Aya A; Mohamed, Sherok A; Abd-Elmaaboud, Hasna A; El-Awady, Nour E; Mohamed, Rana A; El-Mirghany, Sara A; El-Hady, Sarraa W; Abd-ElRahman, Mohamed M; Aboshanab, Khaled |
| 18 | Mar-2025 | Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogens | Selim, Heba Mohammed Refat M; Gomaa, Fatma Alzahraa M; Alshahrani, Mohammad Y; Morgan, Radwa N; Aboshanab, Khaled |
| 19 | 13-Jan-2025 | Deciphering the nature and statistical optimization of antimicrobial metabolites of two endophytic bacilli | Isleem, Raghda S; Eid, Ahmed M; Hassan, Saad El-Din; Aboshanab, Khaled ; El-Housseiny, Ghadir S |
| 20 | 3-Jan-2025 | Response Surface D-Optimal Design for Optimizing Fortimicins Production by Micromonospora olivasterospora and New Synergistic Fortimicin-A-Antibiotic Combinations | Selim, Heba Mohammed Refat M; Gomaa, Fatma Alzahraa M; Alshahrani, Mohammad Y; Aboshanab K. |